drugset
drugset / Trial / NCT02175407

A Study to Assess the Interaction Between ASP1707 and Itraconazole in Healthy Female Subjects

NCT02175407 ↗

Phase 1 Completed 14 enrolled Astellas Pharma Europe B.V.
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study to explore the effect of multiple oral doses of itraconazole on the pharmacokinetics of a single oral dose of ASP1707 in healthy female subjects. This study will also evaluate the safety and tolerability of a single oral dose of ASP1707 alone and in combination with itraconazole.

Timeline

Start
2014-04
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule — Oral
Subject OPIGOLIX Other / unclassified — Oral

Indications

No indication recorded.